CfD competition


CfD DTU is offering the opportunity to win a free pilot study using Olink® Target 48 cytokine panel, along with a statistical data analysis prepared by our collaborative partner Biogenity

This panel has been specifically developed for inflammation studies, containing 45 carefully selected protein assays for key pathways associated with cytokine signaling and other inflammatory processes. With just 1 µL of sample, this panel can provide insights into:

  • Treatment safety and efficacy
  • Patient immune responses
  • Disease phenotype
  • Inflammatory diseases
  • Molecular mechanisms underlying disease.

Read more about Biogenity here.

To be in the running to win this opportunity, please submit an abstract in the form below by the 19.04.24. To access the form features, ensure that cookies are enabled.

It's important to note that Centre for Diagnostics has no interest in using your project ideas or data without your consent. If necessary, we are willing to sign a Non-Disclosure Agreement (NDA) and/or a Data Processing Agreement (DPA) to protect your intellectual property.

The following terms and conditions apply to this competition:

  • Sample type is either serum or plasma and for a maximum of 40 samples.
  • Abstract has a limit of 250 words.
  • Shipping of the samples must be ready to ship by the end of May 2024.
  • The winner will be announced 26.04.2024. 


What is Olink

Olink® Target 96 & 48 panels for targeted protein biomarker discovery enable faster, better-informed decisions in human protein biomarker research by providing high-multiplex immunoassays that do not compromise on either data quality or performance. Identifying multiple proteins that form a signature is more powerful and reliable than looking at a single protein.

How does it work?
The unique technology behind the Olink platforms, Proximity Extension Assay (PEA) technology, is an innovative dual recognition, DNA-coupled methodology providing exceptional readout specificity. PEA enables high multiplex, rapid throughput biomarker analysis without compromising on data quality.


When submitting my abstract I give consent for the Centre for Diagnostics, DTU Health Technology, and Olink to process personal information, including my name, phone number, address, and email address, for the purpose of sending newsletters and for contacting me. This is, necessary when obtaining consent for automated decisions (Article 22.2).
Consent can be revoked at any time by writing to; Subject line: Revoke consent.


I accept Centre for Diagnostics DTU Competition: Terms and Conditions

  1. Eligibility: The competition held by the Centre for Diagnostics DTU ("the Centre") is open to residents of the European Union who are 18 years of age and over. Employees of the Centre and their immediate family members are not eligible to participate.
  2. Submission Guidelines: Participants are required to submit an abstract of approx. 250 words in English, adhering to the theme specified by the Centre. Submissions must be original and not previously published elsewhere.
  3. Prize: The winning abstract will receive a pilot study conducted by the Centre. No cash alternatives will be offered. The prize is non-transferable and cannot be exchanged or redeemed for monetary value.
  4. Travel and Accommodation: The prize does not include travel expenses, accommodation, or any other incidental expenses. Winners are responsible for arranging and covering their own travel and accommodation, if applicable, to participate in the pilot study.
  5. Judging Process: All abstract submissions will be judged based on pre-determined criteria by a panel selected by the Centre. The judges' decision is final and binding in all matters related to the competition.
  6. Winner Notification: The winner will be notified directly via the contact information provided at the time of submission. If the winner cannot be contacted or does not respond within a specified timeframe, the Centre reserves the right to select an alternative winner.
  7. Publicity: By participating in the competition, participants grant the Centre the right to use their name, likeness, and submitted abstract for promotional purposes without any further compensation.
  8. Intellectual Property: Participants retain ownership of the intellectual property rights of their submitted abstracts. However, by entering the competition, participants grant the Centre a non-exclusive, royalty-free license to use, reproduce, modify, adapt, publish, and display the abstract for purposes related to the competition and promotion of the Centre.
  9. Data Protection: Personal information provided by participants will be used solely for the purpose of administering the competition and will not be shared with third parties without consent, except as required by law.
  10. Governing Law: The competition and these terms and conditions will be governed by and construed in accordance with the laws of Denmark.
  11. Acceptance of Terms: Participation in the competition constitutes acceptance of these terms and conditions. The Centre reserves the right to amend, suspend, or terminate the competition or these terms and conditions at any time without prior notice.